• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡啶二羧酸衍生物作为新型德里金属β-内酰胺酶-1的抑制剂

Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.

作者信息

Chen Allie Y, Thomas Pei W, Stewart Alesha C, Bergstrom Alexander, Cheng Zishuo, Miller Callie, Bethel Christopher R, Marshall Steven H, Credille Cy V, Riley Christopher L, Page Richard C, Bonomo Robert A, Crowder Michael W, Tierney David L, Fast Walter, Cohen Seth M

机构信息

Department of Chemistry and Biochemistry, University of California, San Diego , La Jolla, California 92093, United States.

Division of Chemical Biology & Medicinal Chemistry, College of Pharmacy, University of Texas , Austin, Texas 78712, United States.

出版信息

J Med Chem. 2017 Sep 14;60(17):7267-7283. doi: 10.1021/acs.jmedchem.7b00407. Epub 2017 Aug 30.

DOI:10.1021/acs.jmedchem.7b00407
PMID:28809565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5599375/
Abstract

The efficacy of β-lactam antibiotics is threatened by the emergence and global spread of metallo-β-lactamase (MBL) mediated resistance, specifically New Delhi metallo-β-lactamase-1 (NDM-1). By utilization of fragment-based drug discovery (FBDD), a new class of inhibitors for NDM-1 and two related β-lactamases, IMP-1 and VIM-2, was identified. On the basis of 2,6-dipicolinic acid (DPA), several libraries were synthesized for structure-activity relationship (SAR) analysis. Inhibitor 36 (IC = 80 nM) was identified to be highly selective for MBLs when compared to other Zn(II) metalloenzymes. While DPA displayed a propensity to chelate metal ions from NDM-1, 36 formed a stable NDM-1:Zn(II):inhibitor ternary complex, as demonstrated by H NMR, electron paramagnetic resonance (EPR) spectroscopy, equilibrium dialysis, intrinsic tryptophan fluorescence emission, and UV-vis spectroscopy. When coadministered with 36 (at concentrations nontoxic to mammalian cells), the minimum inhibitory concentrations (MICs) of imipenem against clinical isolates of Eschericia coli and Klebsiella pneumoniae harboring NDM-1 were reduced to susceptible levels.

摘要

金属β-内酰胺酶(MBL)介导的耐药性的出现和全球传播,尤其是新德里金属β-内酰胺酶-1(NDM-1),对β-内酰胺类抗生素的疗效构成了威胁。通过基于片段的药物发现(FBDD),鉴定出了一类针对NDM-1以及两种相关β-内酰胺酶IMP-1和VIM-2的新型抑制剂。基于2,6-二吡啶甲酸(DPA),合成了几个文库用于构效关系(SAR)分析。与其他锌(II)金属酶相比,抑制剂36(IC = 80 nM)对MBL具有高度选择性。虽然DPA表现出从NDM-1螯合金属离子的倾向,但36形成了稳定的NDM-1:锌(II):抑制剂三元复合物,这通过1H NMR、电子顺磁共振(EPR)光谱、平衡透析、色氨酸固有荧光发射和紫外可见光谱得到了证明。当与36共同给药(浓度对哺乳动物细胞无毒)时,亚胺培南对携带NDM-1的大肠杆菌和肺炎克雷伯菌临床分离株的最低抑菌浓度(MICs)降低到了敏感水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/a4b6580f6648/nihms900005f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/6fe3fde7f361/nihms900005f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/7e22739a6ec4/nihms900005f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/23f9e785fb2a/nihms900005f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/28bce2bbd2cb/nihms900005f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/f17e9b85b93c/nihms900005f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/0329c29feed0/nihms900005f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/b365b40779e6/nihms900005f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/b863227814a5/nihms900005f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/955d61c9b207/nihms900005f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/a4b6580f6648/nihms900005f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/6fe3fde7f361/nihms900005f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/7e22739a6ec4/nihms900005f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/23f9e785fb2a/nihms900005f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/28bce2bbd2cb/nihms900005f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/f17e9b85b93c/nihms900005f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/0329c29feed0/nihms900005f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/b365b40779e6/nihms900005f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/b863227814a5/nihms900005f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/955d61c9b207/nihms900005f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3967/5599375/a4b6580f6648/nihms900005f10.jpg

相似文献

1
Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.吡啶二羧酸衍生物作为新型德里金属β-内酰胺酶-1的抑制剂
J Med Chem. 2017 Sep 14;60(17):7267-7283. doi: 10.1021/acs.jmedchem.7b00407. Epub 2017 Aug 30.
2
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.曲霉茉莉素A衍生物作为新型NDM-1抑制剂以克服抗生素耐药性的合成及生物学评价
Bioorg Med Chem. 2017 Oct 1;25(19):5133-5141. doi: 10.1016/j.bmc.2017.07.025. Epub 2017 Jul 14.
3
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.含有硫醇作为金属β-内酰胺酶抑制剂的获批药物:对抗多重耐药细菌的策略
J Med Chem. 2015 Apr 23;58(8):3626-30. doi: 10.1021/jm501844d. Epub 2015 Apr 13.
4
Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.二吡啶酸类似物抑制金属β-内酰胺酶的研究。
ChemMedChem. 2019 Jul 3;14(13):1271-1282. doi: 10.1002/cmdc.201900172. Epub 2019 May 24.
5
Machine Learning Models Identify Inhibitors of New Delhi Metallo-β-lactamase.机器学习模型鉴定新德里金属β-内酰胺酶抑制剂。
J Chem Inf Model. 2024 May 27;64(10):3977-3991. doi: 10.1021/acs.jcim.3c02015. Epub 2024 May 10.
6
Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.基于TPA的锌螯合剂作为金属β-内酰胺酶抑制剂的合成及临床前评价
ACS Infect Dis. 2018 Sep 14;4(9):1407-1422. doi: 10.1021/acsinfecdis.8b00137. Epub 2018 Aug 2.
7
New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada.加拿大肺炎克雷伯菌和大肠埃希菌中的新德里金属β-内酰胺酶。
Emerg Infect Dis. 2011 Jan;17(1):103-6. doi: 10.3201/eid1701.101358.
8
Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.具有抗抗生素耐药性金属β-内酰胺酶抑制作用的三唑抑制剂的结构研究。
Bioorg Med Chem. 2020 Aug 1;28(15):115598. doi: 10.1016/j.bmc.2020.115598. Epub 2020 Jun 18.
9
Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance.头孢菌素前药抑制剂克服金属β-内酰胺酶驱动的抗生素耐药性。
Chemistry. 2021 Feb 19;27(11):3806-3811. doi: 10.1002/chem.202004694. Epub 2021 Jan 8.
10
The present danger of New Delhi metallo-β-lactamase: a threat to public health.新德里金属β-内酰胺酶的当前危险:对公共健康的威胁。
Future Microbiol. 2020 Dec;15(18):1759-1778. doi: 10.2217/fmb-2020-0069. Epub 2021 Jan 6.

引用本文的文献

1
A Selective Pyridinedicarbohydrazide-based "naked-eye" Fluorescent Probe for Detecting Cu Ions in Aqueous Solutions.一种基于选择性吡啶二碳酰肼的“裸眼”荧光探针,用于检测水溶液中的铜离子。
J Fluoresc. 2025 Sep 2. doi: 10.1007/s10895-025-04473-x.
2
Development and evaluation of 1,4,7-triazacyclononane-coupled β-lactams against metallo-β-lactamase producing bacteria.针对产金属β-内酰胺酶细菌的1,4,7-三氮杂环壬烷偶联β-内酰胺的研发与评估
RSC Adv. 2025 Jul 7;15(29):23427-23440. doi: 10.1039/d5ra01842k. eCollection 2025 Jul 4.
3
Evaluation of Bioactive Compounds from Cucumis anguria L. as Potential Inhibitors of Antibiotic-Resistant New Delhi Metallo-β-Lactamase (NDM-1).

本文引用的文献

1
AIM-1: An Antibiotic-Degrading Metallohydrolase That Displays Mechanistic Flexibility.目的 1:一种具有机制灵活性的抗生素降解金属水解酶。
Chemistry. 2016 Dec 5;22(49):17704-17714. doi: 10.1002/chem.201602762. Epub 2016 Oct 25.
2
Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase.双噻唑烷类:一种模拟底物的骨架作为NDM-1碳青霉烯酶抑制剂。
ACS Infect Dis. 2015 Nov 13;1(11):544-54. doi: 10.1021/acsinfecdis.5b00046. Epub 2015 Jul 20.
3
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates.
对来自刺角瓜的生物活性化合物作为抗生素耐药性新德里金属β-内酰胺酶(NDM-1)潜在抑制剂的评估。
ACS Omega. 2025 May 30;10(22):23684-23695. doi: 10.1021/acsomega.5c02627. eCollection 2025 Jun 10.
4
Mutation of an active site-adjacent residue in VIM indirectly dictates interactions with and blunts inhibition by D-captopril.波形蛋白中活性位点相邻残基的突变间接决定了与D-卡托普利的相互作用,并减弱了其抑制作用。
J Inorg Biochem. 2025 Jun 10;271:112975. doi: 10.1016/j.jinorgbio.2025.112975.
5
Bibliometrics Analysis and Knowledge Mapping of Fragment-Based Drug Design Research: Trends from 2015 to 2024.基于片段的药物设计研究的文献计量学分析与知识图谱:2015年至2024年的趋势
Drug Des Devel Ther. 2025 May 22;19:4245-4262. doi: 10.2147/DDDT.S518489. eCollection 2025.
6
Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design.喹啉探索:通过合理药物设计开发下一代治疗药物的犬尿喹啉酸策略
Pharmaceuticals (Basel). 2025 Apr 22;18(5):607. doi: 10.3390/ph18050607.
7
REL/DPA/AVI method: a novel approach for rapid detection of carbapenemase-producing Enterobacterales directly from positive blood cultures based on optical density.REL/DPA/AVI方法:一种基于光密度直接从阳性血培养物中快速检测产碳青霉烯酶肠杆菌科细菌的新方法。
J Clin Microbiol. 2025 Jun 11;63(6):e0196024. doi: 10.1128/jcm.01960-24. Epub 2025 May 12.
8
Functional and structural analyses of IMP-27 metallo-β-lactamase: evolution of IMP-type enzymes to overcome Zn(II) deprivation.IMP-27金属β-内酰胺酶的功能与结构分析:IMP型酶为克服锌离子缺乏的进化过程
Microbiol Spectr. 2024 Nov 7;12(12):e0039124. doi: 10.1128/spectrum.00391-24.
9
Current Strategy for Targeting Metallo-β-Lactamase with Metal-Ion-Binding Inhibitors.当前针对金属-β-内酰胺酶的金属离子结合抑制剂的策略。
Molecules. 2024 Aug 21;29(16):3944. doi: 10.3390/molecules29163944.
10
Gas Chromatography-Ion Mobility Spectrometry Reveals Acetoin as a Biomarker for Carbapenemase-Producing Klebsiella pneumoniae.气相色谱-离子淌度谱法揭示乙酰-3-羟丁酮是产碳青霉烯酶肺炎克雷伯菌的生物标志物。
Med Sci Monit. 2024 Jul 31;30:e944507. doi: 10.12659/MSM.944507.
环状硼酸酯抑制金属β-内酰胺酶、丝氨酸β-内酰胺酶和青霉素结合蛋白的结构基础。
Nat Commun. 2016 Aug 8;7:12406. doi: 10.1038/ncomms12406.
4
Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes.双噻唑烷对交叉分类金属β-内酰胺酶的抑制作用揭示了多种结合模式。
Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3745-54. doi: 10.1073/pnas.1601368113. Epub 2016 Jun 14.
5
The biological inorganic chemistry of zinc ions.锌离子的生物无机化学
Arch Biochem Biophys. 2016 Dec 1;611:3-19. doi: 10.1016/j.abb.2016.04.010. Epub 2016 Apr 23.
6
Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2.基于片段的针对金属β-内酰胺酶NDM-1和VIM-2的抑制剂支架发现
Bioorg Med Chem Lett. 2016 Apr 15;26(8):1973-7. doi: 10.1016/j.bmcl.2016.03.004. Epub 2016 Mar 3.
7
Antibacterial drug discovery in the resistance era.耐药时代的抗菌药物发现。
Nature. 2016 Jan 21;529(7586):336-43. doi: 10.1038/nature17042.
8
Investigating the position of the hairpin loop in New Delhi metallo-β-lactamase, NDM-1, during catalysis and inhibitor binding.研究新德里金属β-内酰胺酶NDM-1中发夹环在催化和抑制剂结合过程中的位置。
J Inorg Biochem. 2016 Mar;156:35-9. doi: 10.1016/j.jinorgbio.2015.10.011. Epub 2015 Oct 22.
9
Discovery of Novel Inhibitor Scaffolds against the Metallo-β-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment Screening.基于表面等离子体共振(SPR)的片段筛选发现针对金属β-内酰胺酶VIM-2的新型抑制剂支架
J Med Chem. 2015 Nov 12;58(21):8671-82. doi: 10.1021/acs.jmedchem.5b01289. Epub 2015 Oct 27.
10
Probing metallo-β-lactamases with molecular fragments identified by consensus docking.用通过共识对接鉴定的分子片段探测金属β-内酰胺酶。
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5243-6. doi: 10.1016/j.bmcl.2015.09.056. Epub 2015 Sep 28.